Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
103.16
-2.50 (-2.37%)
Feb 21, 2025, 4:00 PM EST - Market closed
Merit Medical Systems Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Merit Medical Systems stock have an average target of 109.8, with a low estimate of 87 and a high estimate of 128. The average target predicts an increase of 6.44% from the current stock price of 103.16.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Merit Medical Systems stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 6 | 6 | 6 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $114 → $116 | Buy | Reiterates | $114 → $116 | +12.45% | Jan 29, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $114 → $115 | Buy | Maintains | $114 → $115 | +11.48% | Jan 29, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $127 → $128 | Strong Buy | Maintains | $127 → $128 | +24.08% | Jan 29, 2025 |
| Needham | Needham | Strong Buy Maintains $109 → $122 | Strong Buy | Maintains | $109 → $122 | +18.26% | Jan 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $110 → $114 | Buy | Maintains | $110 → $114 | +10.51% | Jan 21, 2025 |
Financial Forecast
Revenue This Year
1.38B
from 1.26B
Increased by 9.75%
Revenue Next Year
1.51B
from 1.38B
Increased by 9.13%
EPS This Year
3.43
from 1.62
Increased by 111.63%
EPS Next Year
3.81
from 3.43
Increased by 11.21%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.4B | 1.6B | 1.7B | |||
| Avg | 1.4B | 1.5B | 1.6B | |||
| Low | 1.3B | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 13.3% | 13.4% | 11.6% | |||
| Avg | 9.8% | 9.1% | 6.3% | |||
| Low | 4.9% | 3.3% | -0.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3.55 | 4.01 | 4.52 | |||
| Avg | 3.43 | 3.81 | 4.28 | |||
| Low | 3.27 | 3.48 | 3.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 119.1% | 17.0% | 18.4% | |||
| Avg | 111.6% | 11.2% | 12.3% | |||
| Low | 102.0% | 1.5% | 3.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.